GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
GSK (GSK) is reportedly suing Pfizer (PFE) and partner BioNTech (BNTX) for patent infringement over the use of certain mRNA ...
The mRNA vaccine maker, which has lost most of its value since early 2021, is undergoing an “organizational redesign” that will eliminate 150 positions.
A federal court in Massachusetts has granted Pfizer and BioNTech’s motion to put on hold Moderna’s lawsuit over alleged ...
The ruling represents the first decision on validity in ongoing patent litigation between CureVac and BioNTech in Germany, involving eight CureVac intellectual property rights. Price Action ...
CureVac shares are trading lower after the company announced a proposed public offering of common stock.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its ...
Not even a beer at the movies is spared from shrinkflation, alleges a lawsuit against Cinemark. And one man is spearheading the fight against what he considers false advertising on his beer pour.
The lawsuit, filed in Texas federal court on Tuesday, claims Cinemark’s 24-ounce cups aren’t true to size and can only be filled with a maximum of 22 ounces of liquid. It claims the alleged ...
Leerink Partners analyst Mani Foroohar maintained a Buy rating on CureVac (CVAC – Research Report) on April 16. The company’s shares closed yesterday at $2.57. According to TipRanks ...